Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models-Reference-Cited by-同舟云学术

Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models

Published:2023-06 Issue: Volume:214 Page:105605
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Cong Yu^ORCID,Lee Ji Hyun^ORCID,Perry Donna L.^ORCID,Cooper Kurt,Wang Hui^ORCID,Dixit Saurabh,Liu David X.,Feuerstein Irwin M.,Solomon Jeffrey^ORCID,Bartos Christopher,Seidel Jurgen^ORCID,Hammoud Dima A.^ORCID,Adams Ricky,Anthony Scott M.,Liang Janie,Schuko Nicolette^ORCID,Li Rong,Liu Yanan,Wang Zhongde,Tarbet E. Bart^ORCID,Hischak Amanda M.W.^ORCID,Hart Randy,Isic Nejra,Burdette Tracey,Drawbaugh David^ORCID,Huzella Louis M.,Byrum Russell,Ragland Danny,St Claire Marisa C.^ORCID,Wada Jiro^ORCID,Kurtz Jonathan R.,Hensley Lisa E.,Schmaljohn Connie S.,Holbrook Michael R.^ORCID,Johnson Reed F.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference61 articles.

1. An immune-based biomarker signature is associated with mortality in COVID-19 patients;Abers;JCI Insight,2021

2. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome;Azar;Expert Rev. Mol. Diagn,2020

3. Inflammatory response in lungs and extrapulmonary sites detected by [(18)F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus;Bai;Eur. J. Nucl. Med. Mol. Imag.,2021

4. SARS-CoV-2, COVID-19 and the aging immune system;Bartleson;Nature Aging,2021

5. COVID-19 autopsies, Oklahoma, USA;Barton;Am. J. Clin. Pathol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of therapeutic antibody efficacy against multiple SARS-CoV-2 variants in the hamster model;Antiviral Research;2024-10